- Tandem Diabetes Care will hold its annual meeting online on May 20, 2026.
- Shareholders will vote to elect nine directors for one-year terms expiring at the 2027 annual meeting.
- Items for approval include an advisory vote on named executive officer compensation and an amended 2023 long-term incentive plan to increase authorized shares.
- Proposals also include certificate of incorporation amendments on director removal and officer liability limits, plus ratification of Ernst and Young as independent auditor.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tandem Diabetes Care Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001438133-26-000028), on March 27, 2026, and is solely responsible for the information contained therein.
Comments